Skip to main content
Veterinary Medicines

Thiamavance 10 mg/ml oral solution for cats

Authorised
  • Thiamazole

Product identification

Medicine name:
Thiamavance 10 mg/ml oral solution for cats
Thiamavance 10 mg/ml šķīdums iekšķīgai lietošanai kaķiem
Active substance:
  • Thiamazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Thiamazole
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB02
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • Cardboard box containing 1 bottle of 30 ml and 1 oral syringe of 1 ml graduated in 0.5 mg.
  • Cardboard box containing 1 bottle of 30 ml and 1 oral syringe of 1 ml graduated in 1.25 mg

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/25/0078
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0449/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/02/2026

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2026
Download

Package Leaflet

English (PDF)
Published on: 10/02/2026
Download

Labelling

English (PDF)
Published on: 10/02/2026
Download